Nutritional Management of Patients with Fatty Acid Oxidation Disorders
Nutrients · 2024
DOI: 10.3390/nu16162707 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Luis Peña-Quintana und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology and Nutrition Unit, Insular Materno-Infantil University Hospital Complex, Asociación Canaria de Investigación Pediátrica, …. Hauptthemen laut MEDLINE: Fatty Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Society for the Study of Inborn Errors of Metabolism (AECOM).
Abstract (Originalsprache)
Treatment of fatty acid oxidation disorders is based on dietary, pharmacological and metabolic decompensation measures. It is essential to provide the patient with sufficient glucose to prevent lipolysis and to avoid the use of fatty acids as fuel as far as possible. Dietary management consists of preventing periods of fasting and restricting fat intake by increasing carbohydrate intake, while maintaining an adequate and uninterrupted caloric intake. In long-chain deficits, long-chain triglyceride restriction should be 10% of total energy, with linoleic acid and linolenic acid intake of 3–4% and 0.5–1% (5/1–10/1 ratio), with medium-chain triglyceride supplementation at 10–25% of total energy (total MCT+LCT ratio = 20–35%). Trihepatnoin is a new therapeutic option with a good safety and efficacy profile. Patients at risk of rhabdomyolysis should ingest MCT or carbohydrates or a combination of both 20 min before exercise. In medium- and short-chain deficits, dietary modifications are not advised (except during exacerbations), with MCT contraindicated and slow sugars recommended 20 min before any significant physical exertion. Parents should be alerted to the need to increase the amount and frequency of carbohydrate intake in stressful situations. The main measure in emergency hospital treatment is the administration of IV glucose. The use of carnitine remains controversial and new therapeutic options are under investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Gastroenterology and Nutrition Unit, Insular Materno-Infantil University Hospital Complex, Asociación Canaria de Investigación Pediátrica, Centro de Investigación Biomédica en Red de la Fisiopatología de la Ob…
- Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM), 28221 Majadahonda, Spain.
- Metabolic and Nutrition Unit, Hospital Universitari i Politècnic la Fe, 46026 Valencia, Spain.
ORCID-Profile: Luis Peña-Quintana
Förderung
- Spanish Society for the Study of Inborn Errors of Metabolism (AECOM)
Zitieren
APA
Peña-Quintana, L., & Correcher-Medina, P. (2024). Nutritional Management of Patients with Fatty Acid Oxidation Disorders. Nutrients. https://doi.org/10.3390/nu16162707
Vancouver
Peña-Quintana L, Correcher-Medina P. Nutritional Management of Patients with Fatty Acid Oxidation Disorders. Nutrients. 2024. doi:10.3390/nu16162707
BibTeX
@article{PeaQuintana2024,
author = {Peña-Quintana, Luis and Correcher-Medina, Patricia},
title = {Nutritional Management of Patients with Fatty Acid Oxidation Disorders},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16162707}
}
EUVIMED